BaseClear BV Certified to Provide NimbleGen Sequence Capture Services in the Netherlands
Product News Apr 27, 2011
Roche NimbleGen, a Roche has announced that the Netherlands-based genomic service provider BaseClear BV has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
BaseClear has been certified to process customer samples using the NimbleGen SeqCap EZ Library (solution phase) workflow for next-generation sequencing, most specifically using SeqCap EZ Exome version 2.0 products, in their lab in Leiden.
They passed a rigorous certification test plan to achieve precise experimental standards to officially join the Roche NimbleGen CSP Program. BaseClear is the first Certified Service Provider for this application in Europe and the second provider worldwide.
“We are very pleased to join the Roche NimbleGen CSP program, which complements our existing accreditations and certifications. BaseClear always strives to deliver the highest level of service to our customers”, said Bas Reichert, commercial director of BaseClear.
Reichert continued, “I am proud that we are the first company in Europe as a Roche NimbleGen Certified Service Provider for SeqCap EZ Library. With the Nimblegen SeqCap EZ Exome capture system we can extend our service portfolio and will be able to deliver a high quality and cost effective solution to the human genetics research community. The certification is an additional guarantee for our high quality standard, clearly outlines our commitment to providing the best possible exome capture service, and ensures that we will have early access to new product variants and improvements.”
“Roche NimbleGen is pleased to welcome BaseClear as the first European certified service provider of our SeqCap EZ application. BaseClear’s commitment to high-quality genomic and sequencing services in the Netherlands is key in providing researchers with access to cutting edge genomic tools such as the NimbleGen SeqCap EZ Workflow in the Benelux region" said Dr. Frank Pitzer, CEO of Roche NimbleGen, Inc.